Axillary reverse mapping (ARM) in clinically node positive breast cancer patients
- 1 January 2015
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 41 (1) , 59-63
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?European Journal of Surgical Oncology, 2013
- Stage migration due to introduction of the sentinel node procedure: a population-based studyBreast Cancer Research and Treatment, 2008
- Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC TrialJNCI: Journal of the National Cancer Institute, 2006
- The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearanceJournal of Surgical Oncology, 2005
- One-year morbidity after sentinel node biopsy and breast surgeryThe Breast, 2005
- Relapse and Morbidity in Patients Undergoing Sentinel Lymph Node Biopsy Alone or With Axillary Dissection for Breast CancerArchives of Surgery, 2003
- Comparison of morbidity between axillary lymph node dissection and sentinel node biopsyEuropean Journal of Surgical Oncology, 2003
- Morbidity of Breast Cancer Patients Following Complete Axillary Dissection or Sentinel Node Biopsy Only: A Comparative EvaluationBreast Cancer Research and Treatment, 2002
- Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinomaCancer, 2000
- The role of axillary lymph node dissection in breast cancer managementBreast Cancer, 1997